Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2023/2/3 申報
- 申報編號
- 0001883850-23-000031
- 申報時間
- 2023/2/3
- 交易日
- 2023/2/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 11 筆非衍生性交易。公開市場賣出合計 $7.56 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/2/1 | Common Stock | S賣出處分 | −2 | $752.11F2 | −$1,504.22 | 19,345 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −18 | $753.54F3 | −$13,563.72 | 19,327 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −17 | $754.45F4 | −$12,825.65 | 19,310 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −17 | $755.50F5 | −$12,843.5 | 19,293 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −24 | $756.77F6 | −$18,162.48 | 19,269 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −2 | $757.29F7 | −$1,514.58 | 19,267 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −7 | $758.58F8 | −$5,310.06 | 19,260 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −4 | $759.65F9 | −$3,038.6 | 19,256 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −4 | $760.40F10 | −$3,041.6 | 19,252 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −3 | $761.58F11 | −$2,284.74 | 19,249 | 直接 | |
| 2023/2/1 | Common Stock | S賣出處分 | −2 | $762.17F12 | −$1,524.34 | 19,247 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $752.02 to $752.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 18 shares of Company stock on February 1, 2023 at prices ranging from $753.05 to $753.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $754.08 to $754.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $755.11 to $755.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 24 shares of Company stock on February 1, 2023 at prices ranging from $756.18 to $756.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $757.02 to $757.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2023 at prices ranging from $758.29 to $758.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $759.30 to $759.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $760.09 to $760.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F11
Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2023 at prices ranging from $761.49 to $761.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F12
Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $762.15 to $762.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。